Vaccinex Reports that KEYNOTE B-84 has Reached Targeted Enrollment for Pre-planned Interim Analysis By Investing.com
AdminVaccinex (VCNX) Reports that KEYNOTE B-84 has Reached Targeted Enrollment for Pre-planned Interim Analysis Vaccinex, Inc. (Nasdaq: NASDAQ:), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and…